In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Is Clinique’s ‘Fresh Pressed’ A Natural Claim? UK’s Ad Authority Issues Ruling

Executive Summary

Fushi Wellbeing – which markets a range of organic, fresh-pressed face oils derived from the cherry seed, baobab seed and argan nut, among other natural sources – challenged Clinique’s Fresh Pressed line name in light of the brand’s heavy reliance on chemically derived ingredients.

You may also be interested in...



'Natural’ Versus ‘Nature Inspired’: UK Ad Regulator Rules In Competitive Dispute

The oft-raised question of how consumers interpret natural claims has come up again in the Advertising Standards Authority’s dispute resolution forum in the UK. PZ Cussons, which markets Original Source shower gel with “100% Natural Fragrance,” brought a challenge against Unilever/Radox, targeting the latter’s “100% Nature Inspired Fragrance” claim on similar products.

J&J Agrees To $6.75M Aveeno Active Naturals Class Settlement

The firm failed in motions to dismiss plaintiff claims and block class certification in a suit alleging that Aveeno Active Naturals products are falsely advertised because they contain synthetic ingredients. Meanwhile, class certification was granted recently in a separate case concerning Aveeno Baby "natural" claims, which could portend another settlement to come.

L'Oreal, Lauder Optimistic About Innovations In Challenging 2017 Climate

The pure-play beauty leaders continue to grow in a challenging global climate, both looking to recent and upcoming launches to keep them on an upward trajectory.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel